DHRM [Dehaier Medical Systems] 20-F: (Original Filing)
[TABLE OF CONTENTS Item 1. Identity of Directors, Senior Management and Advisers 1 Item 2. Offer Statistics and Expected Timetable 1 Item 3. Key Information 1 Item 4. Information on the Company 16 Item 4A. Unresolved Staff Comments 33 Item 5. Operating and Financial Review and Prospects 33 Item 6. Directors, Senior Management and Employees 45 Item 7. Major Shareholder] [I, Ping Chen, certify that: (1) I have reviewed this Form 20-F of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [Certification of Principal Financial Officer Huili (Alisa) Li, certify that: I, (1) I have reviewed this Form 20-F of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Ping Chen] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Huili (Alisa) Li, certify that: (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Huili (Alisa) Li Chief Financial Officer (Principal Financial Officer)] [Dehaier Medical Systems Reports Full Year 2014 Financial Results Company to Conduct Conference Call at 8:30 a.m. EDT on April 30, 2015 BEIJING, April 30, 2015 -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"), which develops, markets and sells medical devices and wearable sleep respiratory products in China, today reported its financial results for the fiscal year]